hyaluronate

(redirected from Dextranomer)
Also found in: Medical, Wikipedia.

hyaluronate

[‚hī·ə′lu̇r·ə‚nāt]
(biochemistry)
A salt or ester of hyaluronic acid.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
These IBAs include autologous fat, cross-linked collagen, graphite-coated zirconium beads, polytetrafluroethylene, silicon, dimethylsulfoxide and ethylene vinyl alcohol copolymers, hyaluronic acid, dextranomer microspheres, and calcium hydroxyapatite (34-36).
Consisting of dextranomer microspheres (80-250 [micro]m) within a viscous matrix of stabilized sodium hyaluronate, DxHA is known to promote collagen and fibroblast formation between individual microspheres, leading to a submucosal bulking effect [3].
The study of the injection of bulking agent NASHA DX -- a dextranomer suspended in stabilised hyaluronic acid, into the anal sphincter in patients with fecal incontinence -- met the goals and demonstrated efficacy and safety.
Sorensen's report was one of a series of papers presented at a session of the AAP's Section on Urology about the use of dextranomer / hyaluronic acid (Deflux, Q-Med Scandinavia Inc.) endoscopic injection therapy for vesicoureteral reflux (VUR).
Containing dextranomer and hyaluronic acid (cross-linked polysaccharides), this product is currently undergoing clinical trials by Q-Med Scandinavia Inc.
Endoscopic treatment with dextranomer hyaluronic acid for complex cases of vescioureteral reflux.
Deflux was developed by Q-Med AB, and contains dextranomer microspheres (80-250 [micro]m) in a gel of nonanimal stabilized hyaluronic acid.
Over the last decades, dextranomer hyaluronic acid (Dx/HA, Deflux, Oceana Therapeutics Ltd, Dublin, Ireland) has become the most commonly used bulking agent worldwide.